Rare diseases
Investigational molecules
Locations
8 Davis Drive, 27709-0003, United States
Aer Therapeutics Inc. demonstrates a focused commitment to advancing treatments for respiratory conditions, with particular emphasis on addressing chronic obstructive pulmonary disease (COPD). The sponsor's research portfolio reflects a dedication to developing novel therapeutic approaches for patients suffering from debilitating lung conditions that significantly impact quality of life and respiratory function.
The company's therapeutic development strategy centers on innovative interventions designed to improve pulmonary outcomes and provide meaningful clinical benefits for individuals with progressive respiratory disorders. This research direction addresses a substantial unmet medical need in the management of chronic lung diseases.
Aer Therapeutics Inc. runs clinical trials in conditions such as Chronic obstructive pulmonary disease, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
